# SOPHiA GENETICS: Where others see data we see answers

> Helping clinicians to generate real\-time, actionable insights for patients with cancer and rare disorders\.

Generated by Yoast SEO v28.2, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Episode 13: From Sick Care to Health Care](https://www.sophiagenetics.com/podcasts/episode-13-from-sick-care-to-health-care/)
- [Request A Demo \- Oncoportal](https://www.sophiagenetics.com/request-a-demo/oncoportal/)
- [Request A Demo \- DDM](https://www.sophiagenetics.com/request-a-demo/ddm/)
- [Request A Demo \- Alamut](https://www.sophiagenetics.com/request-a-demo/alamut/)
- [Episode 12: The Pioneer of the Cloud](https://www.sophiagenetics.com/podcasts/episode-12-the-pioneer-of-the-cloud/)

## Events \& Webinars
- [VI Simposio Internacional de Genética Humana](https://www.sophiagenetics.com/events-webinars/vi-simposio-internacional-de-genetica-humana/)
- [Why tumor\-normal sequencing matters: new data on CHIP detection in liquid biopsy](https://www.sophiagenetics.com/events-webinars/why-tumor-normal-sequencing-matters/)
- [Uncovering copy number variants in comprehensive genomic profiling](https://www.sophiagenetics.com/events-webinars/uncovering-copy-number-variants-in-comprehensive-genomic-profiling/)
- [One Lab's Journey to Close the Interpretation Gap in Oncology Reporting](https://www.sophiagenetics.com/events-webinars/one-labs-journey-to-close-the-interpretation-gap-in-oncology-reporting/)
- [SOPHiA GENETICS™ Global Precision Medicine Forum: ESMO 2026](https://www.sophiagenetics.com/events-webinars/sophia-genetics-global-precision-medicine-forum-esmo-2026/)

## News
- [SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies](https://www.sophiagenetics.com/news/sophia-genetics-enters-collaboration-to-develop-companion-diagnostics-for-precision-oncology-therapies/)
- [SOPHiA GENETICS Reports Second Quarter 2026 Results](https://www.sophiagenetics.com/news/second-quarter-2026-results/)
- [SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026](https://www.sophiagenetics.com/news/financial-results-date-accounce-q2-2026/)
- [SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center ](https://www.sophiagenetics.com/news/sophia-genetics-signs-strategic-collaboration-mou-with-leading-global-cancer-center/): SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology 
- [SOPHiA GENETICS and ARC Regulatory Collaborate to Support EU Clinical Trial Assay Development](https://www.sophiagenetics.com/news/arc-regulatory-collaboration/)

## Resource
- [Article Spotlight: Multimodal ML reanalysis of POSEIDON trial reveals mNSCLC patients most likely to benefit from adding tremelimumab to durvalumab and CT](https://www.sophiagenetics.com/resource/article-spotlight-trident-study/): Despite the achievements in precision medicine, not all patients with metastatic non\-small cell lung cancer without actionable mutations respond to immunotherapy in the same way\. In the TRIDENT study, we combined clinical, genomic, and radiology imaging data from the POSEIDON trial and applied machine learning to help predict the patients with the greatest overall survival benefit from adding tremelimumab to durvalumab and chemotherapy and support a more precise and personalized treatment selection in lung cancer\.
- [Vitrolife Group simplify carrier screening by adopting an Enhanced Exome Solution](https://www.sophiagenetics.com/resource/vitrolife-group-simplify-carrier-screening-by-adopting-an-enhanced-exome-solution/): In this short interview, Arantxa Hervás, CGT Dx Director at Vitrolife Group, shares why her lab moved from a multi\-test NGS model to the SOPHiA DDM™ Enhanced Clinical Exome Solution, and what has changed for them since\.
- [ECP Posters spotlight](https://www.sophiagenetics.com/resource/ecp-posters-spotlight/): We recently presented two posters at the European Congress of Pathology 2024, in Florence, Italy, in collaboration with Janssen Pharmaceutical, a Johnson \& Johnson company\.
- [BCRA poster at ECP 2024](https://www.sophiagenetics.com/resource/bcra-poster-at-ecp-2024/)
- [EGFR poster at ECP 2024](https://www.sophiagenetics.com/resource/egfr-poster-at-ecp-2024/)

## Videos
- [Manage and apply virtual panels](https://www.sophiagenetics.com/video/manage-and-apply-virtual-panels/)
- [OncoPortal Knowledge Base](https://www.sophiagenetics.com/video/oncoportal-knowledge-base/)
- [Create and manage variants filters](https://www.sophiagenetics.com/video/create-a-filter/)
- [Phenotype prioritization](https://www.sophiagenetics.com/video/phenotype-prioritization/)
- [Help Center](https://www.sophiagenetics.com/video/help-center/)

## Optional
- [Sitemap index](https://www.sophiagenetics.com/sitemap_index.xml)